Wells Fargo Maintains Overweight on Glaukos, Raises Price Target to $138

Benzinga Newsdesk www.benzinga.com Positive 59.8%

Neg 0% Neu 0% Pos 59.8%

Wells Fargo analyst Larry Biegelsen maintains Glaukos (NYSE:GKOS) with a Overweight and raises the price target from $135 to $138.